Download Appendix II Trial Acronyms

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Online Appendix for the following JACC article
TITLE: Coronary Stents: Part 2—Looking Forward
AUTHORS: Scot Garg, MB, ChB, Patrick W. Serruys, MD, PhD
Appendix 1 Trial Acronyms
Trial Acronym Trial
ABSORB A bioresorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions
ATLANTA Assessment of The Latest Non-Thrombogenic Angioplasty stent
CARE Cardiomind Sparrow DES Trials
Reference
(112-114,125)
(85,88,90)
(169)
COSTAR Cobalt Chromium Stent With Anti-proliferative for Restenosis
(46,48)
CREATE Multi-Center Registry of Excel Biodegradable Polymer Drug Eluting Stents
(27)
CUSTOM XTENT studies
(33,34)
DEBIUT Drug Eluting Balloon in Bifurcation Trial
(194,197)
DESIRE Double versus Single balloon stent delivery systems for bifurcation lesions
(149)
DIVERGE Drug Eluting Stent Intervention for Treating Side Branches Effectively
(32)
EuroSTAR The European cobalt Stent with Anti-proliferative for Restenosis trial
(47)
EVOLVE
Randomised comparison of the standard and low dose SYNERGY everolimus eluting stent with the PROMUS
(35)
Element stent.
EXCELLA Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System
(14,15,23)
HEALING-II Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth
ISAR-TEST Intracoronary Stenting and Angiographic Restenosis–Test Equivalence Between 2 Drug-Eluting Stents
ISAR-TEST 2 Intracoronary Stenting and Angiographic Restenosis – Test Efficacy of Three Limus Eluting Stents
ISAR-TEST 3
Intracoronary Stenting and Angiographic Restenosis Investigators – Test Efficacy of Rapamycin-eluting Stents
(97-99)
(65)
(82,83)
(80,81)
with Different Polymer Coating Strategies
JACTAX Juxtaposed Abluminal Coating TAXUS stent study
LEADERS Limus Eluted from A Durable versus Erodable Stent coating
NEVO-RES NEVO RES-ELUTION
NOBORI NOBORI stent trials
OCTDESI The Optical Coherence Tomography Drug Eluting Stent Investigation
(41)
(29,30)
(28)
(31,51,54)
(57)
OPEN Stentys coronary bifurcation stent system for the Percutaneous Treatment of de novo lesions in native bifurcated (160,161)
coronary arteries
(186,187)
PACCOCATH ISR Paclitaxel-Coated Balloon Catheter for In-Stent Restenosis
PAINT
Percutaneous Intervention with biodegradable-polymer based paclitaxel-eluting, sirolimus-eluting, or bare stents for (39)
the treatment of de novo coronary lesions
PEPCAD Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease
PERSEUS
A Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element
Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions
(188-190,193,195)
(16,17)
PICCOLETO Paclitaxel-eluting balloon versus paclitaxel-eluting stent in small coronary vessel disease
PISCES The Paclitaxel In-Stent Controlled Elution Study
PLATINUM
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS
(191)
(45)
(35)
Element] for the Treatment of up to Two De Novo Coronary Artery Lesions
PROGRESS AMS Clinical Performance and Angiographic Results in Absorbable Metal Stents study
REMEDEE Randomized Evaluation of an Abluminal sirolimus coated Bio-Engineered Stent
RESOLUTE Evaluation of the new generation zotarolimus-eluting coronary stent system
(116,140)
(37)
(13,18,20-22)
RESORB REVA Endovascular Study of a Bioresorbable Coronary Stent
(36)
SECRITT Santorini Criteria for Investigating and Treating Thin Capped Fibroatheroma Trial
(167)
SERIES
Study of the Supralimus® Sirolimus Eluting Stent in the treatment of patients with real world coronary artery
(26,44)
lesions
SIMPLE Safety and Efficacy of the Infinnium Paclitaxel-Eluting Stent
(40)
TIDE Randomized Trial Comparing Titan vs. Endeavor-stents.
(94)
TiNOX
TITAX-AMI
Randomized Comparison of a Titanium-Nitride-Oxide–Coated Stent With a Stainless Steel Stent for Coronary
(86,91)
Revascularization
A Prospective, Randomized Trial Comparing TITAN-2® Stent and TAXUS-Liberte® Stent in Acute Myocardial
(92,93)
Infarction
TOP TMI Ostial Preservation
(148)
(87,100)
TRIAS-HR TRI-stent Adjudication Study
VESTASYNC Hydroxyapatite Polymer-Free Sirolimus-Eluting Stent for the Treatment of Single De Novo Coronary Lesions
(115)
WHISPER FIM study of the IDEAL Poly (Anhydride Ester) Salicylic acid stent
Please refer the paper’s reference list.
Appendix 2 Devices and Manufacturers
Device
(64,78)
Manufacturer
Adsorbable Metal Stent (AMS) Biotronik, Berlin, Germany
Amazonia PAX Minvasys, Genevilliers, France
Antares TriReme Medical Inc., Pleasanton, CA, USA
Axxess Devax, Lake Forest, CA, USA
BioFREEDOM Biosensors, Morges, Switzerland
BioMatrix Flex Biosensors, Morges, Switzerland
Bioresorbable Vascular Scaffold (BVS) Abbott Vascular, Santa Clara, CA, USA
Cardiomind Sparrow Cardiomind Inc, Sunnyvale, CA, USA
Catania CeloNova Biosciences, Newnan, GA, USA
Combo stent Orbus Neich, Fort Lauderdale, Fl, USA
Coroflex DEBlue B.Braun, Melsungen, Germany
Cypher Cordis, Johnson and Johnson, Warren, NJ, USA
DIOR Eurocor, Bonn, Germany
Elixir DESyne Elixir Medical, Sunnyvale, CA, USA
ENDEAVOR Medtronic, Santa Rosa, CA, USA
ENDEAVOR Resolute Medtronic, Santa Rosa, CA, USA
Excel JW Medical System, Weihai, China
GENIE Acrostak, Winterthur, Switzerland
Genous Orbus Neich, Fort Lauderdale, Fl, USA
IDEAL Bioabsorbable Therapeutics, Inc. Menlo Park, Ca, USA
Igaki-Tamai Kyoto Medical Planning. Co. Ltd., Kyoto, Japan
IN.PACT Falcon Invatec S.r.l., Brescia, Italy
Infinnium Sahajanand Medical, Gujrat, India
Invatec Twin-Rail Invatec S.r.l., Brescia, Italy
JacPro Boston Scientific, Natick, MA, USA
JACTAX Boston Scientific, Natick, MA, USA
Labcoat Element Boston Scientific, Natick, MA, USA
Multi-Link Frontier Abbott Vascular, Santa Clara, CA, USA
NEVO Cordis, Johnson and Johnson, Warren, NJ, USA
Nile Croco Minvasys, Genevilliers, France
Nile Pax Minvasys, Genevilliers, France
NOBORI Terumo, Leuven, Belgium
Paccocath Bayer AG, Leverkusen, Germany
Petal Boston Scientific, Natick, MA, USA
Promus Element Boston Scientific, Natick, MA, USA
REVA Generation I REVA Medical, Inc., San Diego, CA, USA
REZolve REVA Medical, Inc., San Diego, CA, USA
SeQuent Please B.Braun, Melsungen, Germany
Sideguard Cappella, Auburndale, MA, USA
SideKick Y-Med, San Diego, CA, USA
SLK-View Advance Stent Technologies, Pleasanton, CA, USA
Stentys Stentys SAS, Clichy, France
Supralimus Sahajanand Medical, Gujarat, India
SYNERGY Boston Scientific, Natick, MA, USA
TAXUS Liberté Boston Scientific, Natick, MA, USA
TAXUS Element Boston Scientific, Natick, MA, USA
TiNOX Hexacath, Rueil-Malmaison, France
Tryton Tryton Medical, Newton, MA, USA
VESTAsync MIV Therapeutics, Atlanta, GA, USA
vPROTECT Prescient Medical, Inc., Doylestown, PA, USA
Xience V Abbott Vascular, Santa Clara, CA, USA
XTENT Xtent Inc, Menlo Park, CA, USA
Yukon Translumina, Hechingen, Germany
Related documents